Shiro Yui

Shiro Yui

Auto-generated profile, based on publicly available information

Shiro Yui

Center for stem cell and regenerative medicine, Institute of Biomedical Engineering, Institute of Science Tokyo, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2022 in Nature Protocols
Verified
Journal Article
Closed access
PDF file
SWSatoshi Watanabe
Satoshi Watanabe
SKSakurako Kobayashi
Sakurako Kobayashi
NONobuhiko Ogasawara
Nobuhiko Ogasawara
RORyuichi Okamoto
Ryuichi Okamoto
TNTetsuya Nakamura
Tetsuya Nakamura
SYShiro Yui
Shiro Yui

28 November 2022 in Inflammation and Regeneration
Verified
Journal Article
Open access
PDF file
SKSakurako Kobayashi
Sakurako Kobayashi
NONobuhiko Ogasawara
Nobuhiko Ogasawara
SWSatoshi Watanabe
Satoshi Watanabe
YYYosuke Yoneyama
Yosuke Yoneyama
SKSakura Kirino
Sakura Kirino
SYShiro Yui
Shiro Yui
Background: The emerging concepts of fetal-like reprogramming following tissue injury have been well recognized as an important cue for resolving regenerative mechanisms of intestinal epithelium during inflammation. We previously revealed that the remodeling of mesenchyme with collagen fibril induces YAP/TAZ-dependent fate conversion of intestinal/colonic epithelial cells covering the wound bed towards fetal-like progenitors. To fully elucidate the mechanisms underlying the link between extracellular matrix (ECM) remodeling of mesenchyme and fetal-like reprogramming of epithelial cells, it is critical to understand how collagen type I influence the phenotype of epithelial cells. In this study, we utilize collagen sphere, which is the epithelial organoids cultured in purified collagen type I, to understand the mechanisms of the inflammatory associated reprogramming. Resolving the entire landscape of regulatory networks of the collagen sphere is useful to dissect the reprogrammed signature of the intestinal epithelium. Methods: We performed microarray, RNA-seq, and ATAC-seq analyses of the murine collagen sphere in comparison with Matrigel organoid and fetal enterosphere (FEnS). We subsequently cultured human colon epithelium in collagen type I and performed RNA-seq analysis. The enriched genes were validated by gene expression comparison between published gene sets and immunofluorescence in pathological specimens of ulcerative colitis (UC). Results: The murine collagen sphere was confirmed to have inflammatory and regenerative signatures from RNA-seq analysis. ATAC-seq analysis confirmed that the YAP/TAZ-TEAD axis plays a central role in the induction of the distinctive signature. Among them, TAZ has implied its relevant role in the process of reprogramming and the ATAC-based motif analysis demonstrated not only Tead proteins, but also Fra1 and Runx2, which are highly enriched in the collagen sphere. Additionally, the human collagen sphere also showed a highly significant enrichment of both inflammatory and fetal-like signatures. Immunofluorescence staining confirmed that the representative genes in the human collagen sphere were highly expressed in the inflammatory region of ulcerative colitis. Conclusions: Collagen type I showed a significant influence in the acquisition of the reprogrammed inflammatory signature in both mice and humans. Dissection of the cell fate conversion and its mechanisms shown in this study can enhance our understanding of how the epithelial signature of inflammation is influenced by the ECM niche.

16 February 2024 in iScience
Verified
Journal Article
Open access
NONobuhiko Ogasawara
Nobuhiko Ogasawara
YKYoshihito Kano
Yoshihito Kano
YYYosuke Yoneyama
Yosuke Yoneyama
SKSakurako Kobayashi
Sakurako Kobayashi
SWSatoshi Watanabe
Satoshi Watanabe
SYShiro Yui
Shiro Yui
In normal intestines, a fetal/regenerative/revival cell state can be induced upon inflammation. This plasticity in cell fate is also one of the current topics in human colorectal cancer (CRC). To dissect the underlying mechanisms, we generated human CRC organoids with naturally selected genetic mutation profiles and exposed them to two different conditions by modulating the extracellular matrix (ECM). Among tested mutation profiles, a fetal/regenerative/revival state was induced following YAP activation via a collagen type I-enriched microenvironment. Mechanistically, YAP transcription was promoted by activating AP-1 and TEAD-dependent transcription and suppressing intestinal lineage-determining transcription via mechanotransduction. The phenotypic conversion was also involved in chemoresistance, which could be potentially resolved by targeting the underlying YAP regulatory elements, a potential target of CRC treatment.

13 January 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
SKSakura Kirino
Sakura Kirino
FUFumiya Uefune
Fumiya Uefune
KMKensuke Miyake
Kensuke Miyake
NONobuhiko Ogasawara
Nobuhiko Ogasawara
SKSakurako Kobayashi
Sakurako Kobayashi
SYShiro Yui
Shiro Yui
Plasticity is a central mechanism underlying the robust regenerative capacity of the intestinal epithelium. Two major forms of plasticity have been described: spatial plasticity, in which differentiated cells revert to crypt base columnar cells (CBCs), and fetal reversion into revival stem cells (revSCs). However, the relationship among these two stem cell populations and differentiated cells remains to be clarified. Here, we demonstrated the bidirectional interconversion between CBCs and revSCs. Using lineage tracing, injury models and villus culture, we show that absorptive enterocytes can reprogram into revSCs and regenerate CBCs. These findings position fetal reversion as an entry point to spatial plasticity, establishing a regenerative hierarchy where CBCs, revSCs, and enterocytes collectively orchestrate intestinal repair. Furthermore, we identified revSCs as a highly stress-tolerant stem cell population, whose emergence would preserve the stem cell pool. Our results establish fetal reversion as a cellular escape mechanism safeguarding epithelial regeneration under inflammatory conditions.

6 February 2023 in Journal of Gastroenterology
Verified
Journal Article
Closed access
PDF file
SWSatoshi Watanabe
Satoshi Watanabe
NONobuhiko Ogasawara
Nobuhiko Ogasawara
SKSakurako Kobayashi
Sakurako Kobayashi
SKSakura Kirino
Sakura Kirino
MIMasami Inoue
Masami Inoue
SYShiro Yui
Shiro Yui

28 March 2026 in Nature Communications
Verified
Journal Article
Open access
TMTomohiro Muto
Tomohiro Muto
GIGo Ito
Go Ito
HKHiromune Katsuda
Hiromune Katsuda
YHYui Hiraguri
Yui Hiraguri
SFSatoru Fujii
Satoru Fujii
RORyuichi Okamoto
Ryuichi Okamoto
Paneth cell metaplasia (PCM) is a phenomenon in which Paneth cells, typically found in the small intestine, appear in the colonic epithelium of patients with ulcerative colitis (UC). Our study demonstrates that the PCM occurrence correlates with disease duration and active inflammation. Furthermore, we identified IL-22, an inflammation-associated cytokine, as a key regulator that promotes PCM formation in the colonic epithelium through suppression of Notch signaling and induces REG3A expression within metaplastic niches. In vitro, we show that Reg3a directly enhances cell proliferation and promotes wound healing using mouse colonic organoids. In vivo, Reg3aΔIEC mice in both acute and chronic DSS-induced colitis models exhibit delayed wound healing. Additionally, studies conducted with patient-derived human colonic organoids revealed that REG3A administration stimulates cell proliferation and accelerates wound healing. Together, these findings support a protective role of PCM-associated REG3A in the colonic epithelium of patients with UC.